Faricimab: an investigational agent targeting the Tie-2/Angiopoietin pathway and VEGF-A for the treatment of retinal diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Faricimab: an investigational agent targeting the Tie-2/Angiopoietin pathway and VEGF-A for the treatment of retinal diseases
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2021-01-21
DOI
10.1080/13543784.2021.1879791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation and Care of Patients with Diabetic Retinopathy
- (2020) Lee M. Jampol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-life data in the treatment of neovascular age-related macular degeneration. Results from the I-maculaweb registry evaluated in a single Italian Medical Retina center
- (2020) Massimo Nicolo' et al. OPHTHALMOLOGICA
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Jayashree Sahni et al. JAMA Ophthalmology
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Arshad M. Khanani et al. JAMA Ophthalmology
- Retinal Vasculitis After Administration of Brolucizumab Resulting in Severe Loss of Visual Acuity
- (2020) Srinivas Sai A. Kondapalli JAMA Ophthalmology
- Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab
- (2020) Majid Khan et al. Cells
- Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world
- (2020) Ashish Sharma et al. EYE
- Real-world outcomes after 36 months treatment with ranibizumab 0.5 mg in patients with visual impairment due to diabetic macular edema (BOREAL-DME)
- (2020) Pascale Massin et al. OPHTHALMIC RESEARCH
- THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES
- (2020) Jeffrey S. Heier et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab
- (2020) Jordi Monés et al. OPHTHALMOLOGY
- Analysis of a Systematic Review About Blue Light–Filtering Intraocular Lenses for Retinal Protection
- (2019) Laura E. Downie et al. JAMA Ophthalmology
- Simultaneous Inhibition of Angiopoietin-2 and VEGF-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial
- (2019) Jayashree Sahni et al. OPHTHALMOLOGY
- Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
- (2019) Richard H Foxton et al. EMBO Molecular Medicine
- Diabetic Retinopathy in the Context of Patients with Diabetes
- (2019) Olga Simó-Servat et al. OPHTHALMIC RESEARCH
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration
- (2019) Lorenzo Ferro Desideri et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Innovative therapies for neovascular age-related macular degeneration
- (2019) Hasenin Al-Khersan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease
- (2019) Rehan M. Hussain et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Faricimab: expanding horizon beyond VEGF
- (2019) Ashish Sharma et al. EYE
- A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
- (2018) Ye He et al. BMC Ophthalmology
- Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
- (2018) Charles C. Wykoff et al. Journal of Managed Care & Specialty Pharmacy
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of on-demand therapy every 4 or 8 weeks
- (2018) Sankha Amarakoon et al. ACTA OPHTHALMOLOGICA
- Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
- (2017) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGICA
- Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
- (2016) Jörg T Regula et al. EMBO Molecular Medicine
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR Protocol T
- (2015) Charles C. Wykoff et al. Ophthalmic Surgery Lasers & Imaging Retina
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage
- (2013) Andrew V. Benest et al. PLoS One
- Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy
- (2012) Sirpa Loukovaara et al. ACTA OPHTHALMOLOGICA
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now